Viva Biotech HoldingsFRA:VB0 +2.59%47 Days Inventory is 102.24 as of Dec. 2025, which is 75% above its 10-year median of 58.41. GuruFocus rates FRA:VB0 with a GF Score™ of 47/100 and a GF Value™ of €0.08 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, Viva Biotech Holdings ranks better than 71.32% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Viva Biotech Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.78.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Viva Biotech Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.36.
Viva Biotech Holdings (FRA:VB0) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Viva Biotech Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Viva Biotech Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Viva Biotech Holdings Days Inventory Related Terms
Viva Biotech Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for Viva Biotech Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VB0 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Viva Biotech Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viva Biotech Holdings Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Viva Biotech Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viva Biotech Holdings (FRA:VB0) has a Days Inventory of 102.24 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Viva Biotech Holdings and its competitors. This is 75% above median its historical median of 58.41. Over the past decade, Viva Biotech Holdings' Days Inventory has ranged from 8.73 to 103.94. According to the industry distribution chart, Viva Biotech Holdings ranks #183 out of 638 companies in the Biotechnology industry, placing it in the top 28.7%.
Is Viva Biotech Holdings' Days Inventory too high?
Viva Biotech Holdings' current Days Inventory of 102.24 is 75% above median its 10-year median of 58.41. Over the past 10 years, this metric has ranged from a low of 8.73 to a high of 103.94. The Biotechnology industry median Days Inventory is 183.88. Viva Biotech Holdings' value of 102.24 is 44.4% below this industry median. Based on the distribution chart, Viva Biotech Holdings ranks #183 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Viva Biotech Holdings has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viva Biotech Holdings' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Viva Biotech Holdings ranks #183 out of 638 companies for Days Inventory. This puts Viva Biotech Holdings in the upper half of its industry. The industry median Days Inventory is 183.88. Viva Biotech Holdings' value of 102.24 is 44.4% below this benchmark. Historically, Viva Biotech Holdings' own Days Inventory has ranged from 8.73 to 103.94 over the past decade. While the company's 10-year median is 58.41 vs. the industry median of 183.88, Viva Biotech Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viva Biotech Holdings's current Days Inventory of 102.24 is 44.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Viva Biotech Holdings and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viva Biotech Holdings's current Days Inventory is 102.24, which is 75% above median its own 10-year median of 58.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viva Biotech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Viva Biotech Holdings (FRA:VB0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.08, compared to a current price of €0.12 — trading 48.8% above its estimated fair value. The current Days Inventory is 102.24, which is 75% above median its 10-year median of 58.41 and 44.4% below the Biotechnology industry median of 183.88. Viva Biotech Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Viva Biotech Holdings (FRA:VB0), the current Days Inventory is 102.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viva Biotech Holdings (FRA:VB0) Overvalued in 2026?
Based on GuruFocus' analysis, Viva Biotech Holdings stock appears to be overvalued.
The current stock price of €0.12 is trading 48.8% above its estimated GF Value™ of €0.08.
GuruFocus considers Viva Biotech Holdings to be Significantly Overvalued.
Key valuation signals for FRA:VB0:
Days Inventory: 102.24 (75% above median its 10-year median of 58.41)
GF Value™: €0.08 vs. price of €0.12 (48.8% above fair value)
Industry Position: 44.4% below the Biotechnology median (#183 of 638)
No single metric tells the full story. See the FRA:VB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
47GF Score
Get the complete analysis for FRA:VB0
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VB0 has been successfully added to your 
